Glucose-Lowering Effects of DPP-4 Inhibitors Require beta-Cell Incretin Receptors
Publication
, Conference
Capozzi, ME; D'Alessio, DA; Campbell, J
Published in: DIABETES
June 1, 2017
Duke Scholars
Published In
DIABETES
EISSN
1939-327X
ISSN
0012-1797
Publication Date
June 1, 2017
Volume
66
Start / End Page
LB93 / LB93
Publisher
AMER DIABETES ASSOC
Related Subject Headings
- Endocrinology & Metabolism
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Capozzi, M. E., D’Alessio, D. A., & Campbell, J. (2017). Glucose-Lowering Effects of DPP-4 Inhibitors Require beta-Cell Incretin Receptors. In DIABETES (Vol. 66, pp. LB93–LB93). AMER DIABETES ASSOC.
Capozzi, Megan E., David A. D’Alessio, and Jonathan Campbell. “Glucose-Lowering Effects of DPP-4 Inhibitors Require beta-Cell Incretin Receptors.” In DIABETES, 66:LB93–LB93. AMER DIABETES ASSOC, 2017.
Capozzi ME, D’Alessio DA, Campbell J. Glucose-Lowering Effects of DPP-4 Inhibitors Require beta-Cell Incretin Receptors. In: DIABETES. AMER DIABETES ASSOC; 2017. p. LB93–LB93.
Capozzi, Megan E., et al. “Glucose-Lowering Effects of DPP-4 Inhibitors Require beta-Cell Incretin Receptors.” DIABETES, vol. 66, AMER DIABETES ASSOC, 2017, pp. LB93–LB93.
Capozzi ME, D’Alessio DA, Campbell J. Glucose-Lowering Effects of DPP-4 Inhibitors Require beta-Cell Incretin Receptors. DIABETES. AMER DIABETES ASSOC; 2017. p. LB93–LB93.
Published In
DIABETES
EISSN
1939-327X
ISSN
0012-1797
Publication Date
June 1, 2017
Volume
66
Start / End Page
LB93 / LB93
Publisher
AMER DIABETES ASSOC
Related Subject Headings
- Endocrinology & Metabolism
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences